| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V110768 | UCM1400 | UCM1400 is a subtype-selective melatonin receptor (MT) modulator. | |
|
V3725 | Tasimelteon | 609799-22-6 | Tasimelteon (formerly BMS-214778; VEC-162; trade name: Hetlioz), a novel circadian regulator, is the first medication approved by both FDA and European Medicines Agency (EMA) for the treatment of Non-24-hour Sleep-Wake Disorder (Non-24), or sleep-wake disorder in blind individuals. |
|
V29191 | Agomelatine L(+)-Tartaric acid (S-20098) | 824393-18-2 | Agomelatine L(+)-Tartaric acid is a potent antidepressant acting as a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively. |
|
V33697 | Agomelatine hydrochloride (S-20098 HCl) | 1176316-99-6 | Agomelatine hydrochloride (S-20098 HCl) is a potent antidepressant acting as a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively. |